C

CSL

Develops and delivers biotherapies and vaccines

Director US Business Analytics

Data & AnalyticsConfirmed live in the last 24 hours
Full-timePennsylvania, USANo salary listedIn-person

About the Job

Requirements

  • A bachelor's degree in a quantitative or business field is required.
  • A minimum of 12 years of relevant healthcare or pharmaceutical consulting experience, supported by the ability to influence stakeholders and senior leadership in developing data-driven brand strategies and tactical execution plans, is required.
  • Strong interpersonal skills to build rapport and credibility with CSL leaders, from therapeutic-area-aligned commercial and marketing leaders to commercial leadership, are required.
  • Knowledge of relevant US business, legal, compliance, and regulatory requirements is required.
  • Experience leading and managing teams in a complex and fast-paced environment is required.
  • Advanced knowledge of pharmaceutical commercial data, including IQVIA, Komodo, and Symphony, supported by proven analytical skills using Microsoft Office Suite, is required.

Responsibilities

  • Define analytics priorities and operating plans across the HAE and Immunoglobulin portfolio to support commercial strategy and business performance objectives.
  • Lead and develop business analytics tools to analyze and advise on complex business problems and issues across CSL Behring and Vifor, focusing on the HAE and Ig US portfolio of products.
  • Partner with the US Vice President of Marketing and US Marketing leadership team by owning and providing analysis that delivers quantitative market, competitor, and brand insights.
  • Manage the team responsible for business analytics supporting CSL inline portfolio products, focusing on HAE and Ig and late-stage pre-launch development products.
  • Drive innovation in business analytics deployment, data science, and actionable insights.
  • Contribute to portfolio and brand strategy development through metrics, key performance indicator dashboards, and performance indicators.
  • Synthesize quantitative and qualitative information into actionable recommendations using strong business acumen.
  • Recommend analytics strategies, operating plans, and performance measurement frameworks that affect portfolio performance and commercial objectives.
  • Lead US commercial business analytics professionals in developing, planning, and executing commercial data modeling and scenario analysis.
  • Lead continuous improvement efforts across analytics approaches, data identification, and team capability development.
  • Use quantitative techniques to analyze market dynamics and provide decision support, translating complex data into strategic recommendations that influence portfolio priorities and commercial decisions.
  • Direct work through managed resources and offshore delivery centers, ensuring prioritization and efficient delivery of large, complex cross-functional initiatives supporting business and portfolio objectives.

Desired Qualifications

  • An MBA or other postgraduate qualification is preferred.
  • Global, matrixed, cross-functional experience is preferred.
  • Experience in specialty or rare disease data across multiple data sources is strongly preferred.
  • Knowledge of the US plasma ecosystem is strongly preferred, including multi-product therapeutic-area portfolio management, complex contracting approaches, and understanding and communicating the business implications of these aspects across company regions to stakeholders to support decision-making.
  • Knowledge of business intelligence tools such as Power BI and Tableau is preferred.
  • Knowledge of SAP and Model N is strongly preferred.

About the Company

CSL

Develops and delivers biotherapies and vaccines

CSL is a global biotechnology company that develops and delivers biotherapies and influenza vaccines. It focuses on plasma-derived and recombinant therapies for rare and serious diseases and sells to healthcare providers, hospitals, and governments across the Americas, Asia Pacific, and Europe. Its product range includes treatments for rare diseases, influenza vaccines, and antivenoms, produced through its R&D, manufacturing, and distribution operations. CSL differentiates itself by offering the broadest portfolio of plasma-derived and recombinant therapies and by leveraging its global footprint and emphasis on diversity to reach diverse markets. The company’s main goal is to save lives and protect health by expanding access to high-quality therapies and vaccines worldwide.

Company size
10,001+
Company stage
IPO
Headquarters
Parkville, Australia
Founded
1916

Recently Posted Jobs

Explore more opportunities at CSL

See more jobs